In recent years, medical resuscitation has seen the emergence of a very special pulmonary pathology syndrome, called acute respiratory distress syndrome (ARDS). This syndrome, described in 1967, has attracted a great deal of medical research.

Acute respiratory distress syndrome is a pathological condition caused by acute damage to the alveolar-capillary membrane in the lungs due to various causes, leading to progressive respiratory failure and failure to respond to high doses of oxygen.

ARDS causes serious complications such as deep vein thrombosis, stress-induced gastrointestinal bleeding, malnutrition, psychosis, etc. Therefore, early detection has a great impact on the effectiveness of treatment. So what are the clinical manifestations of the disease? What are the diagnostic criteria and what are the diagnostic approaches?

Although extensive research has been conducted to better understand the pathogenesis of Acute Respiratory Distress Syndrome (ARDS), there is no treatment or medication that can reduce the mortality rate of ARDS.

According to the 2012 Berlin criteria, ARDS is divided into mild, moderate and severe levels. At the same time, the Conference also provides treatment recommendations corresponding to the severity of the disease, including artificial ventilation strategies, the use of sedatives, muscle relaxants and other supportive treatments.

Acute Respiratory Distress Syndrome (ARDS) is a clinical syndrome characterized by acute hypoxemia, appearing suddenly and progressing rapidly after a lung disease or disease in another organ, with chest X-ray showing bilateral diffuse lesions.

Adult acute respiratory distress syndrome (ARDS) is a clinical syndrome characterized by rapid onset of severe dyspnea, hypoxemia, and diffuse pulmonary infiltrates leading to respiratory failure.